Background Tuberculosis, along with HIV, is the leading cause of mortality and morbidity
globally. Despite the fact that several primary studies have been conducted on the incidence …

Managing pediatric tuberculosis (TB) remains a public health problem requiring urgent and
long-lasting solutions as TB is one of the top ten causes of ill health and death in children as …

High levels of adherence to antiretroviral therapy (ART) are essential to promoting viral
suppression and consequential good treatment outcomes. Adolescents living with HIV …

Advances in pediatric TB care are promising, the result of decades of advocacy, operational
and clinical trials research, and political will by national and local TB programs in high …

Background People living with human immunodeficiency virus (HIV) are more likely to
develop tuberculosis (TB), and their co-infection (HIV-TB) increases the risk of death. We …

Children and adolescents living with HIV continue to be impacted disproportionately by
tuberculosis as compared to peers without HIV. HIV can impact TB screening and diagnosis …

Adolescents and young adults (AYA, ages 10–24 years) comprise a uniquely important but
understudied population in global efforts to end tuberculosis (TB), the leading infectious …

Objective To map which tuberculosis care models are best suited for children and
adolescents. Methods We conducted a sco** review to assess the impact of …

Background Children with human immunodeficiency virus (HIV, CWH) are at high risk of
tuberculosis (TB) and face poor outcomes, despite antiretroviral therapy (ART). We …

In September 2023, the second United Nations High-Level Meeting on the Fight Against
Tuberculosis (UN HLM) provided an important opportunity to reflect on progress towards …